25 QUESTIONS / SHORT ANSWERS FIRST
What do you need to know about TB-500?
TB-500 has animal clues but no proven human benefit. The answers keep it apart from the beta-4 protein, so you can see what may matter to your injury and what remains unknown.
What the compound is and where it comes from
You may see TB-500 described as the whole protein. It isn't. The drug is a short section made by a lab to mirror thymosin beta-4. The copy and the full beta-4 protein don't have the same proof.
What part of the protein TB-500 copies
TB-500 comes from a lab and copies numbered parts 17 through 23, the spot that holds actin [1]. The whole thymosin beta-4 protein weighs about 4963 daltons, while the copy weighs about 889 daltons [5]. Those lab weights show they're different sizes, not that either one heals people.
What the TB-500 name does and doesn't tell you
The initials TB refer to thymosin beta. The 500 is a product name, not an amount or dose [1]. The name doesn't tell you whether the product works. It also doesn't mean FDA approved it.
What researchers hoped TB-500 might change
Studies have looked at repair, cell motion, and new blood vessels. Heart, brain, and hair work mostly used animals and the whole beta-4 protein [5]. Those studies don't prove the TB-500 beta-4 copy helps people. For you, the name matters less than whether the proof fits your body and your need.
What moving cells and new blood vessels may change
What TB-500 does when it holds actin
The beta-4 copy held one actin part in a 1:1 match [1]. Actin lets a cell hold form while moving. That lab finding is real. It doesn't prove the copy heals your tissue.
What TB-500 may change in new blood vessels
A 2007 review found that the whole beta-4 protein made vessel-lining cells travel and build vessels [7]. That beta-4 growth may help a wound, but it may also help some tumors [5]. A low-oxygen cell alarm called HIF-1 helped start the change.
What TB-500 hasn't proved about growing vessels
In a dish of living cells, the beta-4 protein raised a natural call for vessel growth [8]. Rodents had beta-4 vessel growth along with wound and hair changes [12]. These early tests don't prove the copy works in people.
What TB-500 hasn't proved about swelling or scars
Animal tests and dish work found the whole beta-4 protein lowered one sign of swelling, called IL-8 in the paper, and reduced some cells that make scar tissue [5]. Human tests haven't found that effect from the copy. I wouldn't count that early finding as a known benefit for your sore joint. You can ask your doctor what vessel growth might mean for your own health.
What animal studies changed in wounds, muscles, and organs
What TB-500 hasn't proved about muscle recovery
A 6-month beta-4 mouse test added muscle fibers, yet strength and heart work stayed the same [5]. No human trial tested the small copy for recovery. User reports can't fill that gap.
What TB-500 hasn't proved about tendons and ligaments
Early beta-4 work found that the whole beta-4 protein pulled young muscle cells into damage [5]. Direct beta-4 tendon and ligament studies are few and used animals. A human result for the small copy is missing.
What rat wound tests leave out about TB-500
In rats, the whole beta-4 protein led to 42% more skin closing after 4 days and 61% more after 7 days [3]. A newer test used a special gel and also found better wound repair [15]. Neither result proved healing in a person given the small copy.
Why rat timing isn't TB-500 healing time for you
The quoted times came from beta-4 work in rats: 42% more closing after 4 days and 61% after 7 days [3]. People don't have a tested healing time. User reports haven't faced a controlled trial.
What TB-500 hasn't proved about your heart
The beta-4 protein helped mouse heart cells after damage [2]. A lab-made support placed by heart tissue gave another result [14], while a pig study didn't [5]. Mixed animal work leaves the small copy's effect unknown.
Why rat stroke results don't prove TB-500 helps you
Rats given 2 or 12 milligrams per kilogram of rat weight could use their bodies better after stroke. Rats did not improve with 18 milligrams per kilogram [4]. Those are animal amounts, not human instructions. They don't prove a brain benefit for you.
Why mouse hair growth doesn't prove TB-500 works for you
The whole beta-4 protein sped hair growth in rats and mice [11]. The study didn't test human hair loss or the small copy. An animal result isn't a hair treatment. Your injury is not a rat wound, so you can't claim the animal result as your own.
What human studies still haven't answered about safety
What TB-500 side effects may matter to you
We have few safety facts for TB-500. A tumor might use added cell movement and new vessels [5]. The whole beta-4 protein caused no serious harm up to 1260 mg in Phase 1, an early safety test [6]. That early test left out the small copy.
What TB-500 studies can and can't say about cancer
Some cancers contain extra thymosin beta-4. The beta-4 protein is linked with tumor spread and new blood vessels [5]. That raises concern but doesn't give your own risk. It also doesn't prove TB-500 causes cancer.
What years of TB-500 use might do
No long human study has put the small copy through a test. We don't know its long-term safety, and the tumor concern isn't settled [5]. Being sold for research doesn't prove years of use are safe.
What human trials have actually tested about TB-500
No completed controlled trial has tested TB-500. The work in people used the whole beta-4 protein in a Phase 1 safety test [6] and in eye drops. A 2026 review still called the compound unapproved and found little proof about human safety [10].
What TB-500 and BPC-157 come from
The first copies a section from a protein throughout your body [1]. BPC-157 copies part of a different protein found in the stomach. A 2026 review says both are unapproved and lack good human proof [10]. Controlled work hasn't found a benefit from using them together, so you have no human trial to settle your likely benefit or long-term risk.
What FDA and sports rules mean for your access
What FDA approval means for TB-500
TB-500 has no FDA approval. On April 22, 2026, FDA stopped showing it in Category 2, a safety-risk list, and marked the request withdrawn [16]. That old Category 2 listing for TB-500 is gone, but FDA hasn't told pharmacies what the change lets them do. The TB-500 legal status page spells out the one-patient pharmacy rule and the July 2026 meeting.
Why sports rules still ban TB-500
Yes, sport rules ban it. TB-500 is prohibited in and out of tested play, and labs can find it after use [5]. A health reason doesn't cancel the rule.
What TB-500's legal status means for you
The answer changes with the setting. FDA no longer shows TB-500 in Category 2, but it hasn't told pharmacies what the withdrawn request means [16]. Sport rules ban it [5], and some places require a prescription under local law. The TB-500 legal status page gives general U.S. facts, not legal advice.
What a compounding pharmacy must have for TB-500
A licensed doctor must assess one patient and write a prescription [20]. The pharmacy must follow either the one-patient rule called 503A or the larger-batch rule called 503B. It also needs a raw drug ingredient FDA allows, and here that ingredient would be TB-500. FDA hasn't said the ingredient is permitted [16].
What FDA's withdrawn request means for TB-500
FDA put the beta-4 piece called TB-500 in Category 2 on September 29, 2023 because it feared the drug might make the immune system overreact and safety facts were missing [16]. The request is now marked withdrawn. Two chemical forms of TB-500 appeared on the July 23–24, 2026 meeting list. FDA hasn't posted how the group voted [18].
What racehorse use says about TB-500
TB-500 turned up as a repair drug in racehorses, so labs made tests to catch it [5]. It isn't approved as a horse medicine. That history explains why much of the direct testing is about doping. Your clinic and pharmacy must answer what they may do before you make your choice.